Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL

Published:2024-07 Issue: Volume: Page:
ISSN:1538-7836
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:Journal of Thrombosis and Haemostasis

Author:

Verbruggen Bert^ORCID,Binder Nikolaus B.,van Velp Petra J.C.,Polenewen Robert,Knöbl Paul^ORCID,Sobas Frédéric,Moore Gary W.^ORCID

Publisher

Elsevier BV

Reference18 articles.

1. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability;Verbruggen;Thromb Haemost,1995

2. Proceedings: a more uniform measurement of factor VIII inhibitors;Kasper;Thromb Diath Haemorrh,1975

3. A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of Canada

4. WFH Guidelines for the Management of Hemophilia panelists and co-authors. WFH guidelines for the management of hemophilia, 3rd edition;Srivastava;Haemophilia,2020

5. Factor VIII inhibitors: von Willebrand factor makes a difference in vitro and in vivo;Shi;J Thromb Haemost,2012

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP